{
    "headline": "Fda Approves Second Booster Shot People Over 50",
    "summary": "The FDA approved a fourth dose of thePfizerandModernaCOVID-19 vaccines for adults over 50.The decision was announced Tuesday morning without consulting the agency\u2019sindependent vaccine advisory committee. Immunocompromised people will also be eligible for a second booster shot at age 12 for Pfizer and age 18 for Moderna. All patients must wait at least four months after their first booster to receive the second. Some reports said the CDC was expected to treat the second booster as optional rather than recommended. The FDA\u2019s announcement came amid worries thatCOVID-19 outbreaks in other countriesheralded an upcomingBA.2 \u201cstealth omicron\u201dwave in the U.S.Coverage was mostly balanced across the spectrum. While coverage was prominently featured in most major outlets across the spectrum, some right-rated outlets likeFox News (Right)andNew York Post (Lean Right)did not appear to cover this story by Tuesday afternoon.",
    "story": {
        "left": [
            "https://www.npr.org/sections/health-shots/2022/03/27/1089072803/the-fda-is-expected-to-authorize-2nd-boosters-for-people-50-and-up"
        ],
        "center": [
            "https://www.reuters.com/world/us/fda-green-lights-second-booster-pfizerbiontech-moderna-covid-shot-older-2022-03-29/"
        ],
        "right": [
            "https://www.dailywire.com/news/fda-approves-second-booster-for-older-adults-some-immunocompromised-people"
        ]
    }
}